[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
[ Thu, Mar 28th 2024 ]: WOPRAI
Leland Gershell Initiated (XERS) at Buy and Held Target at $5 on, Mar 28th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Leland Gershell of Oppenheimer, Initiated "Xeris Biopharma Holdings, Inc." (XERS) at Buy and Held Target at $5 on, Mar 28th, 2024.
Leland has made no other calls on XERS in the last 4 months.
There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Leland's Rating of Hold.
This is the rating of the analyst that currently disagrees with Leland
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $6 on, Thursday, March 7th, 2024